Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativaacne inversa: a prospective study on 23 patients, J Eur Acad Dermatol Venereol, vol.28, pp.125-131, 2014. ,
Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions, Br J Dermatol, vol.135, pp.721-726, 1996. ,
Bacterial biofilms: a common cause of persistent infections, Science, vol.284, issue.5418, pp.1318-1340, 1999. ,
Deciphering the microbiology of hidradenitis suppurativa: a step forward towards understanding an enigmatic inflammatory skin disease, Exp Dermatol, vol.24, pp.736-743, 2015. ,
Biofilms: an emergent form of bacterial life, Nat Rev Microbiol, vol.14, pp.563-75, 2016. ,
A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa, Br J Dermatol, vol.177, pp.987-98, 2017. ,
Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients, Dermatology, vol.219, pp.148-54, 2009. ,
Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline, J R Soc Med, vol.86, pp.729-759, 1993. ,
Bacterial pathogens associated with hidradenitis suppurativa, Emerg Infect Dis, vol.20, 2014. ,
The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study, Clin Infect Dis, vol.65, pp.282-91, 2017. ,
Pathophysiology of hidradenitis suppurativa, Semin Cutan Med Surg, vol.36, pp.47-54, 2017. ,
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa, J Am Acad Dermatol, vol.39, pp.971-975, 1998. ,
Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa, Dermatology, vol.222, pp.49-58, 2011. ,
Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients, J Antimicrob Chemother, vol.71, pp.513-533, 2016. ,
Keratins and skin disease, Cell Tissue Res, vol.360, pp.583-592, 2015. ,
Clindamycin and rifampicin combination therapy for hidradenitis suppurativa, Br J Dermatol, vol.154, pp.977-985, 2006. ,
NOD2 and inflammation: current insights, J Inflamm Res, vol.11, pp.49-60, 2018. ,
Bacteriology of hidradenitis suppurativa/acne inversa: a review, J Am Acad Dermatol, vol.73, issue.5, pp.12-20, 2015. ,
The role of skin and orogenital microbiota in protective immunity and chronic immune-mediated inflammatory disease, Front Immunol, vol.8, 1955. ,
The bacteriology of hidradenitis suppurativa: a systematic review, Exp Dermatol, vol.24, pp.727-758, 2015. ,
Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen, Cutis, vol.57, pp.315-324, 1996. ,
Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series, J Am Acad Dermatol, vol.75, pp.1151-1156, 2016. ,
Investigational drugs in clinical trials for hidradenitis suppurativa, Expert Opin Investig Drugs, vol.27, pp.43-53, 2018. ,
The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa, Dermatology, vol.219, pp.143-150, 2009. ,
Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions, Br J Dermatol, vol.166, pp.98-106, 2012. ,